Literature DB >> 22930615

Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma.

Rajshekhar C Jaka1, Shabber S Zaveri, S P Somashekhar, R V Parameswaran.   

Abstract

INTRODUCTION: Sentinel lymph node biopsy (SLNB) is the standard of care to assess the metastasis in breast carcinoma. Accuracy of intraoperative frozen section examination to evaluate SLN in detecting metastasis is important as it determines the further management of axilla. Primary tumor characteristics determining the metastasis to the lymph node will help in predicting the probability of spread and to determine the nature of disease. It also helps in refining selection of patients for SLNB. We evaluated all these criteria on Indian patients for the better management.
MATERIALS AND METHODS: Between January 2005 and April 2009, 114 consecutive patients of all age group of both sex, with cytology or biopsy proven carcinoma breast, clinical stage T1/T2 N0 M0 at Manipal Comprehensive Cancer Center, Manipal Hospital, Bangalore were subjected to SLNB and introperative frozen examination. First 75 cases had complete axillary clearance irrespective of SLNB result and subsequently, positive cases underwent axillary lymph node dissection (ALND). Age of the patient and primary tumor characteristics like size, grade, lymphovascular invasion (LVI), perineural invasion, ER/PR status, Her2-neu status and histological sub-types were evaluated for predicting the SLN metastasis. Feasibility of SLNB in previously treated patient is also evaluated.
RESULTS: The age of the patient ranged from 23 to 87 years and its association with SLN spread is not significant. Frozen section examination had accuracy of 97.37% in determining metastatic sentinel node with sensitivity of 96.15% and specificity of 100% with value P < 0.001. SLN remained significant indicator of the status of rest of axilla with value P < 0.001. Primary tumor characteristics like histological subtypes, grade (P = 0.353), ER/PR status (P = 0.839), Her2-neu status (P =0.296) were not significantly associated with SLN metastasis. Size of the primary tumor (P = 0.002), LVI (P < 0.001), perineural invasion (P = 0.084+) were significant factors determining the SLN metastasis. SLNB evaluation had no false negative values in previously treated breast.
CONCLUSION: SLNB is a valuable method of determining the axillary nodal metastasis. Intraoperative frozen section examination is highly ac-curate in detecting nodal metastasis. Primary tumor characteristics like size, LVI and perineural invasion are significant in predicting SLN metastasis. SLNB remains an important method of predicting axillary metastasis even in previously treated breast carcinomas.

Entities:  

Keywords:  Breast carcinoma; Metastasis; Sentinel lymph node

Year:  2010        PMID: 22930615      PMCID: PMC3420992          DOI: 10.1007/s13193-010-0008-8

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  59 in total

1.  Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori.

Authors:  M Greco; M Gennaro; P Valagussa; R Agresti; C Ferraris; B Ferrari; C Urban; L Gianni
Journal:  Ann Oncol       Date:  2000-09       Impact factor: 32.976

2.  Intraoperative sentinel lymph node examination by frozen section, immunohistochemistry and imprint cytology during breast surgery--a prospective study.

Authors:  F Celebioglu; M Sylvan; L Perbeck; L Bergkvist; J Frisell
Journal:  Eur J Cancer       Date:  2006-01-30       Impact factor: 9.162

3.  Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers.

Authors:  Jeon Hor Chen; Garima Agrawal; P Carpenter; Rita S Mehta; Orhan Nalcioglu; Min-Ying Su
Journal:  Ann Surg Oncol       Date:  2007-11-15       Impact factor: 5.344

4.  Predictors of axillary lymph node metastasis in T1 breast carcinoma.

Authors:  M Shoup; L Malinzak; J Weisenberger; G V Aranha
Journal:  Am Surg       Date:  1999-08       Impact factor: 0.688

5.  Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis.

Authors:  I A Olivotto; J S Jackson; D Mates; S Andersen; W Davidson; C J Bryce; J Ragaz
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

6.  The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis.

Authors:  A C Voogd; J W Coebergh; O J Repelaer van Driel; R M Roumen; M W van Beek; A Vreugdenhil; M A Crommelin
Journal:  Breast Cancer Res Treat       Date:  2000-07       Impact factor: 4.872

7.  Her-2/neu expression in primary breast cancer with sentinel lymph node metastasis.

Authors:  S David Nathanson; Robert Slater; Deborah Debruyn; Alissa Kapke; Michael Linden
Journal:  Ann Surg Oncol       Date:  2006-01-16       Impact factor: 5.344

8.  Outcomes after localized axillary node recurrence in breast cancer.

Authors:  F C Wright; J Walker; C H L Law; D R McCready
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

9.  Special types of invasive breast cancer, with clinical implications.

Authors:  David L Page
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

10.  Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer.

Authors:  P Carcoforo; L Bergossi; E Basaglia; G Soliani; P Querzoli; E Zambrini; E Pozza; L Feggi
Journal:  Tumori       Date:  2002 May-Jun
View more
  1 in total

1.  Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy.

Authors:  Jing Si; Rong Guo; Huan Pan; Xiang Lu; Zhiqin Guo; Chao Han; Li Xue; Dan Xing; Wanxin Wu; Caiping Chen
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.